Use this dropdown to select your preferred language.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
About Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology.
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
We prioritise innovation in vaccines and specialty medicines to prevent and treat disease.
Science challenges us to push the limits of what is possible. This is why we put science at the center of everything we do. At AstraZeneca every one of our employees makes a difference to patient lives every day. We are inspired by maintaining a culture in which our people feel valued for their ideas and contributions. Our vision is to transform the lives of patients, ensuring all Africans have access to our innovative medicines.
Chiesi is an international company originated in Parma, with more than 80 years of experience on research, production and commercialization of therapeutic solutions in Respiratory, Neonatology, Rare Disease and Special Care.
We are global pharmaceutical Group to be awarded B Corp, recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.
In January 1998, 12 people with vision & courage established in Greece the subsidiary of Chiesi, an international group research-oriented in the areas of AIR/CARE/RARE. ChiesiHellas has become a forward-looking company with strong presence in the local pharmamarket for its culture and governance (2022-24Top Employer, 2024Best Workplace,2024Best Workplace4Women,2022-2024GPTW,2024 Most Sustainable Companies in GR,2021Prix Galien, BCorp since 2019).
As a subsidiary of the Italian company Chiesi Farmaceutici, we are part of a strong international group that develops, manufactures and distributes innovative prescription medicines. As a success-oriented, dynamically growing company, we focus on our employees.
Chiesi UK has 450 employees working in specialist and rare disease therapy areas as well as treating respiratory conditions. We are proud of the contribution we make to public health in the UK. We embrace our shared values and celebrate collaborative working, putting people first and innovation. We have pride in the actions we have taken to address our impact on the environment, acting as a force for good, leading to BCorp© certification in 2019.
Chiesi is an international company originated in Parma, with more than 80 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Air, Care & Rare Therapeutic Areas.
We are the largest global pharmaceutical Group to be awarded B Corp Certification. We want to use business as a force for good and create a positive impact on people, environment and community.
Chiesi is a research-oriented, international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.